News & Media

Carolina Liquid Chemistries Corp. and Diazyme Laboratories Announce Partnership

2nd Feb 2023

Carolina Liquid Chemistries Corp. and Diazyme Laboratories, Inc. Announce Partnership Expanding Test Menu on the Diazyme DZ-Lite™ c270 Benchtop Clinical Chemistry Analyzer, Adding 25 New Assays On Top of Over 50 CLIA Categorized Assays GREENSBORO, NC — (Jan. 20, 2023) – Carolina Liquid Chemistries Corp. (CLC) and Diazyme Laboratories, Inc. (Diazyme) announce a partnership to expan …
read more

Diazyme Laboratories, Inc. Receives Second FDA EUA for COVID-19 Antibody Test

17th Aug 2020

SAN DIEGO, CA - (August 17, 2020) Diazyme announces receiving FDA Emergency Use Authorization (EUA) letter for the Diazyme DZ-Lite SARS-CoV-2 IgM CLIA test. The Diazyme IgM test runs on the fully automated DZ-Lite 3000 Plus chemiluminescence analyzer. "Diazyme continues to serve during the public health emergency with innovative products in COVID-19 serology (antibody) testing. The IgM test is t …
read more

Why D-Dimer test is Important in Severe COVID-19 Infection

3rd Aug 2020

SAN DIEGO, CA Severe COVID-19 infection is associated with high morbidity and mortality with 50% of the deaths determined to be due to coagulopathy1. Studies have revealed that patients with serious infection are more likely to have COVID-19 associated coagulopathy than patients with mild infection, and those who die from COVID-19 are more likely to have met the International Society on Thrombos …
read more

Diazyme Laboratories, Inc. Announces Partnership for COVID-19 Molecular Diagnostics Test

30th Jul 2020

SAN DIEGO, CA (July 30, 2020) Diazyme announces partnership with Maccura Biotechnology (USA) LLC, launching a FDA EUA approved SARS-COV-2 RT-PCR diagnostics test. "Here at Diazyme, we continue to address gaps in testing during the COVID-19 public health emergency. The SARS-CoV-2 Fluorescent PCR Kit- Maccura Biotechnology (USA) LLC is a RT-PCR test intended for the qualitative detection of SARS- …
read more

Diazyme Laboratories, Inc. Receives FDA EUA for COVID-19 Antibody Test

8th Jul 2020

SAN DIEGO, CA  (July 8, 2020) Diazyme announces receiving FDA Emergency Use Authorization (EUA) letter for the Diazyme DZ-Lite SARS-CoV-2 IgG CLIA test. The Diazyme IgG test is run on the fully automated DZ-Lite 3000 Plus chemiluminescence analyzer. "Diazyme has been at the forefront of the development effort to bring timely, high quality COVID-19 serology (antibody) tests during the publi …
read more